Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Cozad Asset Management Inc.

Cozad Asset Management Inc. lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 18.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 26,878 shares of the company’s stock after selling 6,238 shares during the period. Cozad Asset Management Inc.’s holdings in Cardinal Health were worth $2,971,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of CAH. Eastern Bank acquired a new position in shares of Cardinal Health in the third quarter worth $25,000. Cultivar Capital Inc. acquired a new position in shares of Cardinal Health in the second quarter valued at approximately $27,000. Ashton Thomas Private Wealth LLC purchased a new position in Cardinal Health during the 2nd quarter worth $29,000. LRI Investments LLC purchased a new position in Cardinal Health during the first quarter worth about $32,000. Finally, New Covenant Trust Company N.A. acquired a new stake in shares of Cardinal Health in the 1st quarter valued at approximately $40,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 16,573 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total value of $1,812,920.47. Following the sale, the insider now directly owns 75,971 shares in the company, valued at approximately $8,310,467.69. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Cardinal Health news, insider Jessica L. Mayer sold 16,573 shares of Cardinal Health stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the sale, the insider now owns 75,971 shares of the company’s stock, valued at $8,310,467.69. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michelle D. Greene sold 4,000 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $108.85, for a total transaction of $435,400.00. Following the completion of the sale, the insider now directly owns 19,242 shares of the company’s stock, valued at $2,094,491.70. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 113,963 shares of company stock worth $12,379,980. 0.09% of the stock is currently owned by insiders.

Cardinal Health Trading Up 2.1 %

CAH opened at $115.58 on Thursday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $119.13. The firm has a market cap of $27.97 billion, a price-to-earnings ratio of 22.49, a PEG ratio of 1.57 and a beta of 0.60. The company has a fifty day simple moving average of $111.95 and a 200 day simple moving average of $104.31.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business’s revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.73 earnings per share. On average, analysts forecast that Cardinal Health, Inc. will post 7.69 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Thursday, January 2nd. Cardinal Health’s dividend payout ratio is currently 39.30%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Citigroup cut their price target on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a report on Friday, July 19th. Barclays upped their price objective on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research report on Monday. Morgan Stanley raised their target price on shares of Cardinal Health from $119.00 to $127.00 and gave the stock an “overweight” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft raised their price target on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday. Finally, StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $123.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.